Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xing-Gui Chen
Cyclosporine, Prednisone, and High-Dose Immunoglobulin Treatment of Angioimmunoblastic T-Cell Lymphoma Refractory to Prior CHOP or CHOP-like Regimen
Chinese Journal of Cancer
Related publications
Granisetron Plus Aprepitant Versus Granisetron in Preventing Nausea and Vomiting During CHOP or R-Chop Regimen in Malignant Lymphoma: A Retrospective Study
Journal of Pharmaceutical Health Care and Sciences
Conjunctival Angioimmunoblastic T-Cell Lymphoma
Ocular Oncology and Pathology
Nursing
Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (Aitl) and Cxcl12+ Peripheral T-Cell Lymphoma (Ptcl): Preliminary Results From a Phase 2 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Angioimmunoblastic T-Cell Lymphoma: A Rare Subtype of Peripheral T-Cell Lymphoma
Clinical Case Reports
Medicine
Heterozygosity for Roquinsan Leads to Angioimmunoblastic T-Cell Lymphoma-Like Tumors in Mice
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Phase Ii Study of Durvalumab (Anti-Pd-L1) Combined With Either R-Chop or Lenalidomide and R-Chop in Previously Untreated, High-Risk Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Multi-Center Phase Ii Study of Oral Azacitidine (Cc-486) Plus Chop as Initial Treatment for Peripheral T-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
MELK Serves as a Potent Independent Biomarker to Predict Survival of Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-Chop Regimen
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
